A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma

Cancer Statistics, 2006

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth M. Ward et al. · CA A Cancer Journal for Clinicians · 2006 · 5.3K citations · Full text

Epidemiology Of Cancer, Cancer Registration, Mortality Rates +17

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson et al. · Journal of Clinical Oncology · 2000 · 1.3K citations

Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.

Christopher R. Parish, Craig Freeman, Kathryn J. Brown et al. · PubMed · 1999 · 400 citations

Chemoprevention Strategy, Glycobiology, Polysaccharide +19

A Phase I Biological and Pharmacologic Study of the Heparanase Inhibitor PI-88 in Patients with Advanced Solid Tumors

M. Basche, Daniel L. Gustafson, Scott N. Holden et al. · Clinical Cancer Research · 2006 · 95 citations

Probing the Interactions of Phosphosulfomannans with Angiogenic Growth Factors by Surface Plasmon Resonance

Siska Cochran, Caiping Li, Jon K. Fairweather et al. · Journal of Medicinal Chemistry · 2003 · 78 citations

Growth Factor Binding, Surface-enhanced Raman Scattering, Chemistry +22